MXPA01007033A - Heterociclos funcionalizados como moduladores de receptores de quimiocinas. - Google Patents

Heterociclos funcionalizados como moduladores de receptores de quimiocinas.

Info

Publication number
MXPA01007033A
MXPA01007033A MXPA01007033A MXPA01007033A MXPA01007033A MX PA01007033 A MXPA01007033 A MX PA01007033A MX PA01007033 A MXPA01007033 A MX PA01007033A MX PA01007033 A MXPA01007033 A MX PA01007033A MX PA01007033 A MXPA01007033 A MX PA01007033A
Authority
MX
Mexico
Prior art keywords
chemokine receptor
receptor modulators
functionalized heterocycles
heterocycles
functionalized
Prior art date
Application number
MXPA01007033A
Other languages
English (en)
Spanish (es)
Inventor
Jay R Luly
Original Assignee
Millennium Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Millennium Pharm Inc filed Critical Millennium Pharm Inc
Publication of MXPA01007033A publication Critical patent/MXPA01007033A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D491/00—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/12—Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains three hetero rings
    • C07D491/14—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
    • C07D455/02—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing not further condensed quinolizine ring systems

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • AIDS & HIV (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA01007033A 1999-01-13 1999-12-20 Heterociclos funcionalizados como moduladores de receptores de quimiocinas. MXPA01007033A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US11565499P 1999-01-13 1999-01-13
PCT/US1999/030434 WO2000042045A2 (en) 1999-01-13 1999-12-20 Functionalized heterocycles as chemokine receptor modulators

Publications (1)

Publication Number Publication Date
MXPA01007033A true MXPA01007033A (es) 2003-07-21

Family

ID=22362668

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA01007033A MXPA01007033A (es) 1999-01-13 1999-12-20 Heterociclos funcionalizados como moduladores de receptores de quimiocinas.

Country Status (20)

Country Link
EP (1) EP1144415A2 (ko)
JP (1) JP2002534526A (ko)
KR (1) KR20010086166A (ko)
CN (1) CN1344270A (ko)
AP (1) AP2001002228A0 (ko)
AU (1) AU1940900A (ko)
BR (1) BR9916905A (ko)
CA (1) CA2372197A1 (ko)
CZ (1) CZ20012502A3 (ko)
EA (1) EA200100774A1 (ko)
HK (1) HK1044539A1 (ko)
HU (1) HUP0202932A3 (ko)
IL (1) IL144289A0 (ko)
MX (1) MXPA01007033A (ko)
NO (1) NO20013456L (ko)
OA (1) OA11820A (ko)
PL (1) PL349348A1 (ko)
SK (1) SK9972001A3 (ko)
WO (1) WO2000042045A2 (ko)
ZA (1) ZA200106592B (ko)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6951848B2 (en) 2001-03-12 2005-10-04 Millennium Pharmaceuticals, Inc., Functionalized heterocycles as modulators of chemokine receptor function and methods of use therefor
JP2004532209A (ja) * 2001-03-29 2004-10-21 イーライ・リリー・アンド・カンパニー ５−ｈｔ６受容体の拮抗薬としてのｎ−（２−アリールエチル）ベンジルアミン
WO2003035650A1 (fr) * 2001-09-25 2003-05-01 Takeda Chemical Industries, Ltd. Inhibiteur d'entree
EP1604981A4 (en) 2003-03-14 2008-12-24 Ono Pharmaceutical Co NITROGENIC HETEROCYCLIC DERIVATIVES AND MEDICAMENTS CONTAINING THEM AS AN ACTIVE SUBSTANCE
EP2364982A1 (en) 2003-04-18 2011-09-14 ONO Pharmaceutical Co., Ltd. Spiro-piperidine compounds as chemokine receptor antagonists and medicinal use thereof
TWI400232B (zh) 2004-09-13 2013-07-01 Ono Pharmaceutical Co 含氮雜環衍生物及以該含氮雜環衍生物為有效成分之藥劑
JPWO2006129679A1 (ja) 2005-05-31 2009-01-08 小野薬品工業株式会社 スピロピペリジン化合物およびその医薬用途
EP1934219A1 (en) 2005-09-16 2008-06-25 Ranbaxy Laboratories Limited Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors
JP5251127B2 (ja) 2005-10-28 2013-07-31 小野薬品工業株式会社 塩基性基を含有する化合物およびその用途
EP1961744B1 (en) 2005-11-18 2013-04-17 Ono Pharmaceutical Co., Ltd. Basic group-containing compound and use thereof
KR20080102181A (ko) * 2006-02-15 2008-11-24 알러간, 인코포레이티드 스핑고신-1-포스페이트 (에스1피) 수용체 길항제 생물학적 활성을 갖는 아릴 또는 헤테로아릴기를 포함하는 인돌-3-카르보실산 아미드, 에스테르, 티오아미드 및 티올 에스테르 화합물
CN101460458A (zh) 2006-02-15 2009-06-17 阿勒根公司 具有1－磷酸－鞘氨醇(s1p)受体拮抗剂生物活性的带芳基或者杂芳基基团的吲哚－3－羧酸的酰胺、酯、硫代酰胺和硫羟酸酯化合物
EP1995246A4 (en) 2006-03-10 2010-11-17 Ono Pharmaceutical Co NITROGENATED HETEROCYCLIC DERIVATIVE AND MEDICAMENT WITH DERIVATIVE ACTIVE SUBSTANCE
WO2007132846A1 (ja) 2006-05-16 2007-11-22 Ono Pharmaceutical Co., Ltd. 保護されていてもよい酸性基を含有する化合物およびその用途
EA016633B1 (ru) * 2006-05-23 2012-06-29 Общество С Ограниченной Ответственностью "Инновационная Фармацевтика" Замещенные индолы, способ их получения и применения
WO2008016006A1 (en) 2006-07-31 2008-02-07 Ono Pharmaceutical Co., Ltd. Compound having cyclic group bound thereto through spiro binding and use thereof
AU2008206495A1 (en) * 2007-01-11 2008-07-24 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having Sphingosine-1-Phosphate (S1P) receptor antagonist biological activity
US8524917B2 (en) 2007-01-11 2013-09-03 Allergan, Inc. 6-substituted indole-3-carboxylic acid amide compounds having sphingosine-1-phosphate (S1P) receptor antagonist biological activity
WO2010129351A1 (en) 2009-04-28 2010-11-11 Schepens Eye Research Institute Method to identify and treat age-related macular degeneration
WO2011143430A1 (en) 2010-05-12 2011-11-17 Abbott Laboratories Indazole inhibitors of kinase
US20140271680A1 (en) 2011-08-12 2014-09-18 Universite Paris-Est Creteil Val De Marne Methods and pharmaceutical compositions for treatment of pulmonary hypertension
JO3459B1 (ar) 2012-09-09 2020-07-05 H Lundbeck As تركيبات صيدلانية لعلاج مرض الزهايمر
CN104193669B (zh) * 2014-08-01 2016-12-07 大连理工大学 一类阿比朵尔类似物或其盐、其制备方法及应用
WO2016112088A1 (en) * 2015-01-06 2016-07-14 Spero Therapeutics, Inc. Aryloxyacetylindoles and analogs as antibiotic tolerance inhibitors
CN110256324A (zh) * 2019-06-13 2019-09-20 苏州莱安医药化学技术有限公司 一种2-甲基-5-羟基吲哚的制备方法
US11629196B2 (en) 2020-04-27 2023-04-18 Incelldx, Inc. Method of treating SARS-CoV-2-associated hypercytokinemia by administering a human monoclonal antibody (PRO-140) that inhibits CCR5/CCL5 binding interactions

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3549641A (en) * 1966-06-28 1970-12-22 Warner Lambert Pharmaceutical Pyrano pyridines and process for their production
US3518258A (en) * 1967-05-09 1970-06-30 Warner Lambert Pharmaceutical Pyrano(3,2-i)quinolizine and process for the production
US3565903A (en) * 1967-11-24 1971-02-23 Warner Lambert Pharmaceutical Pyrano(2,3-b)quinolines and process for their production
US5635510A (en) * 1993-05-06 1997-06-03 Merrell Pharmaceuticals Inc. Substituted pyrrolidin-3-yl-alkyl-piperidines
HRP960352A2 (en) * 1996-07-26 1998-08-31 Pliva Pharm & Chem Works Novel coumarin quinoline carboxylic acids
EP0966443B1 (en) * 1997-02-26 2009-01-28 Pfizer Inc. Heteroaryl-hexanoic acid amide derivatives, their preparation and their use as selective inhibitors of mip-1-alpha binding to its ccr1 receptor
WO1999038514A1 (en) * 1998-02-02 1999-08-05 Merck & Co., Inc. Cyclic amine modulators of chemokine receptor activity

Also Published As

Publication number Publication date
SK9972001A3 (en) 2002-03-05
CA2372197A1 (en) 2000-07-20
BR9916905A (pt) 2002-01-29
AP2001002228A0 (en) 2001-09-30
OA11820A (en) 2005-08-17
IL144289A0 (en) 2002-05-23
ZA200106592B (en) 2002-08-12
JP2002534526A (ja) 2002-10-15
EP1144415A2 (en) 2001-10-17
WO2000042045A2 (en) 2000-07-20
HUP0202932A3 (en) 2003-07-28
NO20013456L (no) 2001-09-12
EA200100774A1 (ru) 2002-02-28
HK1044539A1 (zh) 2002-10-25
WO2000042045A3 (en) 2000-11-09
HUP0202932A2 (hu) 2002-12-28
CZ20012502A3 (cs) 2002-03-13
AU1940900A (en) 2000-08-01
KR20010086166A (ko) 2001-09-08
PL349348A1 (en) 2002-07-15
NO20013456D0 (no) 2001-07-12
CN1344270A (zh) 2002-04-10

Similar Documents

Publication Publication Date Title
MXPA01007033A (es) Heterociclos funcionalizados como moduladores de receptores de quimiocinas.
ZA200108846B (en) Glucocorticoid receptor modulators.
HK1052037A1 (en) Structural member.
ZA200203181B (en) Positive modulators of nicotinic receptor agonists.
IL145401A0 (en) Chemokine receptor binding heterocyclic compounds
MXPA01013362A (es) Anticuerpos de humano, anti-alfavbeta3 recombinantes, °cidos nucleicos que codifican a los mismos y metodos de uso.
ZA200001665B (en) Suspension device.
EG24361A (en) 4-pyrimiding1-n-acy1.l.phenlalanines
ZA200200477B (en) 2-pyrazolin-5-ones.
ZA200202537B (en) Pour-on-formulations.
HK1053470A1 (en) 4-Pyridinyln-acyl-l-phenylalanines.
HK1030923A1 (en) Hoist.
ZA200203171B (en) Positive modulators of nicotinic receptor agonists.
HK1048825A1 (en) Rubber composition.
MXPA01012165A (es) Antagonistas ccr3 del receptor de quimiocina.
HK1047184A1 (en) Eccentricity compensation apparatus.
HK1030590A1 (en) Crane apparatus.
MXPA02000261A (es) Aminoindanos novedosos.
HK1054382A1 (en) Substituted pyrroles.
ZA200108129B (en) Histidine protein-phosphatase.
MXPA01011286A (es) Derivados de ciclocarbamato como moduladores de receptor de progesterona.
ZA200108207B (en) Vinylcyclohexane-based polymers.
IL145146A0 (en) Stopper
ZA200204581B (en) Nitro-sulfobenzamides.
HK1031254A1 (en) Tachogragh.